Eton Pharmaceuticals, Inc. (ETON)
57.55
+0.47
(+0.82%)
USD |
NASDAQ |
Sep 14, 16:00
57.55
0.00 (0.00%)
After-Hours: 17:31
Eton Pharmaceuticals Market Cap : 1.628B for Sept. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.615B |
| September 10, 2026 | 1.637B |
| September 09, 2026 | 1.664B |
| September 08, 2026 | 1.679B |
| September 04, 2026 | 1.654B |
| September 03, 2026 | 1.695B |
| September 02, 2026 | 1.753B |
| September 01, 2026 | 1.710B |
| August 31, 2026 | 1.710B |
| August 28, 2026 | 1.691B |
| August 27, 2026 | 1.773B |
| August 26, 2026 | 1.772B |
| August 25, 2026 | 1.784B |
| August 24, 2026 | 1.823B |
| August 21, 2026 | 1.796B |
| August 20, 2026 | 1.695B |
| August 19, 2026 | 1.739B |
| August 18, 2026 | 1.794B |
| August 17, 2026 | 1.746B |
| August 14, 2026 | 1.665B |
| August 13, 2026 | 1.154B |
| August 12, 2026 | 1.176B |
| August 11, 2026 | 1.190B |
| August 10, 2026 | 1.195B |
| August 07, 2026 | 1.220B |
| Date | Value |
|---|---|
| August 06, 2026 | 1.263B |
| August 05, 2026 | 1.258B |
| August 04, 2026 | 1.254B |
| August 03, 2026 | 1.235B |
| July 31, 2026 | 1.270B |
| July 30, 2026 | 1.341B |
| July 29, 2026 | 1.317B |
| July 28, 2026 | 1.277B |
| July 27, 2026 | 1.158B |
| July 24, 2026 | 1.165B |
| July 23, 2026 | 1.208B |
| July 22, 2026 | 1.192B |
| July 21, 2026 | 1.182B |
| July 20, 2026 | 1.124B |
| July 17, 2026 | 1.158B |
| July 16, 2026 | 1.018B |
| July 15, 2026 | 1.053B |
| July 14, 2026 | 1.026B |
| July 13, 2026 | 1.022B |
| July 10, 2026 | 1.002B |
| July 09, 2026 | 1.021B |
| July 08, 2026 | 989.60M |
| July 07, 2026 | 1.033B |
| July 06, 2026 | 1.040B |
| July 02, 2026 | 1.026B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 2.335B |
| Pfizer Inc. | 158.20B |
| Elite Pharmaceuticals, Inc. | 283.29M |
| Daré Bioscience, Inc. | 11.14M |
| Liquidia Corp. | 5.818B |
Market Cap Related Metrics
| PE Ratio | 152.13 |
| PS Ratio | 16.69 |
| Price to Book Value | 34.95 |
| Price | 57.55 |
| Earnings Yield | 0.66% |
| Operating PE Ratio | 106.75 |
| Normalized PE Ratio | 150.14 |